Isoplexis Corporation (ISO) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Isoplexis Corporation  (NASDAQ: ISO)


Isoplexis's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Isoplexis's ROI in the fourth quarter of 2022?
Isoplexis Corporation recorded a cumulative net loss of $-106 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on investment (ROI) of -82.36%.

Within the Healthcare sector 907 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 0 to 5270.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM 130.22 % 1101.55 % 257.47 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 91 124 142 158 174
Return On Investment (TTM) -82.36 % -65.66 % -97.6 % -99.25 % -145.92 %
ISO's Overall Ranking # 5270 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -13.82 % 46.05 % 7.12 % 70.75 % 349.8 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -106 -98 -100 -95 -82

ISO Company Profile >> Back to ISO Roi Comparisons >> See Annual ISO Return On Investment



Return On Investment ISO's Ranking
Within: No.
Industry # 29
Sector # 908
Overall # 5270

Return On Investment Statistics
High Average Low
-35.22 %
-56.91 %
-82.36 %
(Sep 30 2022)   (Dec 31 2022)







Financial Statements
Isoplexis's IV. Quarter Investments $ 91 Millions ISO's Balance sheet
Isoplexis's IV. Quarter Income $ -33 Millions Quarterly ISO's Income Statement
ISO's Income by Division See ISO's Income by Division


ISO Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021


Total Investments in Millions 91 174 0 0 0
Y / Y Investment Growth -47.46 % - - - -
Net Income in Millions -106 -82 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -116.03 % -46.91 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ISO's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ISO's Competitors
Subscribers only: Roi for Isoplexis's Suppliers
Subscribers only: Return On Investment for ISO's Customers

Other Ratios
ISO's Roa ISO's Inventory Turnover Ratio ISO's Growth Rates ISO's Dividend Statistics
ISO's Profitability Ratios ISO's Asset Turnover Ratio ISO's Dividend Growth
ISO's Roe ISO's Valuation Ratios ISO's Financial Strength Ratios ISO's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.